The factor structure of extrapyramidal symptoms evaluated using the Drug-Induced Extrapyramidal Symptoms Scale in patients with schizophrenia: Results from the 2016 REAP AP-4 study.
Kubota C, Inada T, Lin SK, Avasthi A, Chee KY, Tanra AJ, Yang SY, Chen LY, Chong MY, Tripathi A, Kallivayalil RA, Grover S, Park SC, Kato TA, Xiang YT, Sim K, Maramis MM, Noor IM, Tan CH, Sartorius N, Shinfuku N.
Kubota C, et al. Among authors: shinfuku n.
Hum Psychopharmacol. 2023 Mar;38(2):e2861. doi: 10.1002/hup.2861. Epub 2022 Dec 3.
Hum Psychopharmacol. 2023.
PMID: 36462184
Clinical Trial.